Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Acura Pharmaceuticals Inc. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The portfolio's active prosecution is concentrated under 1 distinct examiner and 1 distinct art unit. This indicates a narrow and focused approach to the company's current patent filings. Such a centralized prosecution profile is common for companies focusing on a specific therapeutic or pharmaceutical innovation.
The busiest examiner, PHAN, DOAN THI-THUC, is assigned 1 busiest examiner pending action. Because this matches the total count of 1 pending office action, this examiner is responsible for the company's entire active docket. Success in the current prosecution cycle depends on navigating the specific standards and feedback from PHAN, DOAN THI-THUC within the 1 art unit. Legal representatives should prioritize understanding the examination history of this individual, as they are the decision-maker for the 1 pending office action currently before the office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PHAN, DOAN THI-THUC | 1 | 42.7% | +47.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18080379 | METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENTS | PHAN, DOAN THI-THUC | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18080379 | METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENTS | PHAN, DOAN THI-THUC | 1613 | §103DP | Final Rejection | — | Pending | Dec 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial